Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffusing wild type and sterile mosquitoes in an optimal control setting.

Mathematical biosciences·2018
Same author

Optimal control of insects through sterile insect release and habitat modification.

Mathematical biosciences·2013
Same author

BioMaPS: a roadmap for success.

CBE life sciences education·2010
Same author

Modeling optimal intervention strategies for cholera.

Bulletin of mathematical biology·2010
Same author

Blasting neuroblastoma using optimal control of chemotherapy.

Mathematical biosciences and engineering : MBE·2009
Same author

Identification of a chemotactic sensitivity in a coupled system.

Mathematical medicine and biology : a journal of the IMA·2008
Same journal

Modeling the impact of budget limitation on the screening and treatment pathway of HPV-induced precancerous cervical lesions.

Mathematical biosciences and engineering : MBE·2026
Same journal

Modeling the effects of trait-mediated dispersal on coexistence of two species: Competition and non-consumptive predator-prey.

Mathematical biosciences and engineering : MBE·2026
Same journal

A close look at the viral reduction rate in target cell limited models.

Mathematical biosciences and engineering : MBE·2026
Same journal

A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies.

Mathematical biosciences and engineering : MBE·2026
Same journal

Addressing domain shift via imbalance-aware domain adaptation in embryo development assessment.

Mathematical biosciences and engineering : MBE·2026
Same journal

Effect of drug resistance on an HIV epidemic in heterogeneous populations.

Mathematical biosciences and engineering : MBE·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Immunotherapy: an optimal control theory approach.

K Renee Fister1, Jennifer Hughes Donnelly

  • 1Department of Mathematics and Statistics, Murray State University, 6C Faculty Hall, Murray, KY 42071. renee.fister@murraystate.edu.

Mathematical Biosciences and Engineering : MBE
|April 8, 2010
PubMed
Summary
This summary is machine-generated.

Mathematical models show how to eliminate tumors by maximizing immune cells and IL-2. Optimal control theory guides strategies to suppress tumor growth, revealing effective treatment dynamics.

More Related Videos

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Experiment Videos

Last Updated: Jun 14, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Area of Science:

  • Mathematical Biology
  • Immunology
  • Control Theory

Background:

  • Tumor growth and immune response involve complex dynamics.
  • Interleukin-2 (IL-2) is crucial for immune cell function.
  • Optimal control theory can optimize therapeutic interventions.

Purpose of the Study:

  • To develop mathematical models for tumor-immune dynamics.
  • To apply optimal control theory for tumor elimination strategies.
  • To investigate the role of effector cells and IL-2 in cancer therapy.

Main Methods:

  • Formulating mathematical models of tumor-immune cell interactions.
  • Designing optimal control functionals to maximize effector cells and IL-2, while minimizing tumor cells.
  • Proving the existence of bang-bang optimal controls.
  • Coupling state and adjoint systems to characterize optimal controls.
  • Employing numerical analysis for evaluating control strategies.

Main Results:

  • Demonstrated the existence of bang-bang optimal controls for tumor elimination.
  • Characterized optimal control strategies through coupled state-adjoint systems.
  • Identified conditions for tumor eradication based on immune-effector cell and IL-2 dynamics.
  • Numerical simulations validated the effectiveness of the proposed control methods.

Conclusions:

  • Optimal control theory provides a framework for designing effective cancer therapies.
  • Maximizing effector cells and IL-2 concentration is key to tumor elimination.
  • Bang-bang control strategies offer insights into dynamic treatment regimens.
  • Mathematical modeling and numerical analysis are essential for understanding complex biological systems.